Try our Advanced Search for more refined results
Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Brown & Connery
- Tarter Krinsky
- Teitelbaum Law Group
- Duane Morris
- Hagens Berman
- Simmons Hanly
- Goodwin Procter
- Caplin & Drysdale
- Motley Rice
- Debevoise & Plimpton
- HSF Kramer
- Hogan Lovells
- FBT Gibbons
- Morrison & Foerster
- Willkie Farr
- Arnold & Porter
- Dentons
- Ice Miller
- Terrell Hogan
- Bielli & Klauder
- Godfrey & Kahn
- Himes Petrarca
- Manatt Phelps
- Wachtell Lipton
- Hurwitz Fine
- Morris Nichols
- Gilbert LLP
- Troutman
- BatesCarey
- Katten Muchin
- Lowe Stein
- Archer & Greiner
- Katsky Korins
- Brown Rudnick
- Gage Spencer & Fleming
- Pashman Stein
- Doshi Legal Group
- Buchalter LLP
- Crowell & Moring
- Morgan Lewis
- Reed Smith
- Davis Polk
- McDermott Will & Schulte
- Gertz & Rosen
- Consovoy McCarthy
- Porteous Hainkel
- Jones Day
- Porter Hedges
- Kirkland & Ellis
- Bentley & Bruning
- ASK LLP
- Foley & Lardner
- Joseph Hage
- Doster Ullom
- Marino Tortorella
- White & Case
- Boies Schiller
- Spangenberg Shibley
- Cuneo Gilbert
- MoloLamken
- Mintz Levin
- WestLoop Law
- Miller Nash LLP
- Cronin Fried
- Loeb & Loeb
- Diamond McCarthy
- Slevin & Hart
- Plevin & Turner
- Schenck Price
- Bialson Bergen
- Martin S. Rapaport
- Skadden Arps
- Akerman LLP
- Fox Swibel
- Lerner Arnold
- Burke Warren
- Shook Hardy
- Sherrard Roe
- Taft Stettinius
- Sahn Ward
- Cleary Gottlieb
- Simpson Thacher & Bartlett
- Napoli Shkolnik
- D. Miller & Associates
- McGrail & Bensinger
- Marcus & Shapira
- Quinn Emanuel
- ArentFox Schiff
- Pachulski Stang
- King & Spalding
- UB Greensfelder
- Wilk Auslander
- Stevens & Lee
- Faegre Drinker
- Shafferman & Feldman
- Squire Patton
- Blitman & King
- Hughes Socol
- Pillsbury Winthrop
- Robins Kaplan
- WilmerHale
- Blank Rome
- Keller Rohrback
- Kobre & Kim
- Ballard Spahr
- O'Melveny & Myers
- Keller Postman
- Phillips Lytle
- Webb Law Firm
- Kleinberg Kaplan
- Clifford Law Offices
- Barack Ferrazzano
- Stutzman Bromberg
- Levenfeld Pearlstein
- Rothstein Mandell
- Seyfarth Shaw
- MacElree Harvey
- Klehr Harrison
- Pullman & Comley
- Mehri & Skalet
- Tate Law Group LLC
- Lowey Dannenberg
- Williams Mullen
- Waldrep Wall
- Barclay Damon
- Dechert LLP
- Ifrah Law
- Seward & Kissel
- Calfee Halter
- White Coleman & Associates
- Miller Shah
- Susman Godfrey
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- Milbank LLP
Companies
- Teamsters Local 456
- Johnson & Johnson
- Henry Schein Inc.
- Cencora Inc.
- Bristol-Myers Squibb Co.
- Hikma Pharmaceuticals PLC
- Giant Eagle Inc.
- McKesson Corp.
- BDO LLP
- Otis Worldwide Corp.
- Liberty Mutual Insurance Group
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- KVK Tech Inc.
- Collegium Pharmaceutical Inc.
- Noramco Inc.
- Endo International PLC
- Impax Laboratories, Inc.
- Omnicare Inc.
- FTI Consulting Inc.
- Bausch Health Cos. Inc.
- Province LLC
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- DuPont de Nemours Inc.
- Hain Capital Group LLC
- United Parcel Service Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- Ironshore Inc.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Loblaw Cos.
- Tucson Medical Center
- TR Capital Management LLC
- Viatris Inc.
- The Cigna Group
- Alaska Native Tribal Health Consortium
- Anda Inc.
- Walmart Inc.
- AXA XL Ltd.
- Allergan PLC
- BDO USA LLP
- Rubris Inc.
- AlixPartners LLP
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- U.S. District Court for the District of Columbia
- Tennessee Attorney General's Office
- Pala Band of Mission Indians
- Seldovia Village Tribe
- Nez Perce Tribe
- Town of Ramapo, New York
- Jamestown S'Klallam Tribe
- St. Regis Mohawk Tribe
- State of Indiana
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Colorado Attorney General's Office
- Port Gamble S'Klallam Tribe
- Borough of Paramus, New Jersey
- State of Nevada
- Northwestern Band of the Shoshone Nation
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Commonwealth of Massachusetts
- Hopi Tribe
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
April 06, 2023
Purdue Seeking OK To Put Over-The-Counter Biz Up For Sale
Purdue Pharma is seeking permission from a New York bankruptcy judge to put its over-the-counter business up for auction with a $397 million stalking horse bid from a subsidiary of Arcadia Consumer Healthcare.
-
January 24, 2023
Purdue Warns Tribe's NY Lawsuit Could 'Blow Up' Ch. 11 Plan
Purdue Pharma LP urged a New York bankruptcy court on Tuesday to reject a demand from an Indigenous tribe in Canada to lift a freeze on litigation against the bankrupt drugmaker and its Sackler family owners so the tribe can pursue its claims against the Sacklers in state court.
-
November 10, 2022
McKinsey Wants NY Opioid Suits Moved To Bankruptcy Court
McKinsey & Co. is seeking to move a pair of New York state court suits over its alleged role in Purdue Pharma's opioid marketing efforts to bankruptcy court, saying there is a "strong interconnection" between the cases and Purdue's Chapter 11 case.
-
June 21, 2022
Revlon Case Opens, And LATAM Lands Its Ch. 11 Plan
Cosmetics behemoth Revlon Inc. filed for bankruptcy in the midst of a liquidity crisis, a South American airline brings its Chapter 11 plan in for a landing, and the next phase in Puerto Rico's restructuring nears a creditor vote. This is the week in bankruptcy.
-
June 15, 2022
Judge Trims CEO's Bonus Pay At His Last Purdue Hearing
A New York bankruptcy judge on Wednesday wound down more than two and a half years presiding over Purdue Pharma LP's contentious Chapter 11 with a ruling approving a trimmed-down incentive payment package for the opioid maker's CEO.
-
May 24, 2022
Week In Bankruptcy: Dioceses Settle; Wind-Downs Reined In?
Three Roman Catholic dioceses are pushing for approvals of settlements for hundreds of sexual abuse claims in bankruptcy courts, a Delaware state court judge denied a litigation stay in a nonbankruptcy wind-down case, potentially signaling a crackdown, and Purdue Pharma executives got their bonuses approved. This is the week in bankruptcy.
-
May 18, 2022
Purdue Ch. 11 Bonus Plan Gets Court OK, CEO's Delayed
Timing adjustments and tweaks defused the limited objections to a $33.8 million bonus package for key employees of bankrupt Purdue Pharma LP, with the plan winning approval Wednesday from a federal bankruptcy judge in the Southern District of New York.
-
May 17, 2022
The Week In Bankruptcy: Purdue Bonus, PR Pension Appeal
Two dozen states objected to proposed bonus payments for the CEO of bankrupt drugmaker Purdue Pharma, the First Circuit declined to rehear an appeal over changes made to Puerto Rican teacher pensions as part of the island's restructuring, and Affordable Care Act penalties are taxes in bankruptcy court. This is the week in bankruptcy.
-
May 13, 2022
States Say Purdue CEO Should Answer For Opioid Crisis Role
A group of state attorneys general have once again objected to proposed bonus payments for Purdue Pharma LP's CEO, telling a New York bankruptcy judge that he was a part of the corporate culture that led to the national opioid crisis.
-
April 27, 2022
Purdue Ch. 11 Injunction Extended Pending 2nd Circ. Decision
A preliminary injunction barring the pursuit of claims against bankrupt drugmaker Purdue Pharma LP and the Sackler family will be extended for at least another month as the parties await a Second Circuit ruling on an appeal of releases included in the company's confirmed Chapter 11 plan.